Exelon (Rivastigmine) is a drug used to moderate Alzheimer's and Parkinson's diseases. An active agent, rivastigmine, prevents the destruction of acetylcholine, increases the concentration of acetylcholine in the brain and hippocampus. Exelon has a positive effect on cognitive impairment that is usual for Alzheimer's disease. It can slow the formation of amyloid plaques – one of the main pathological signs of Alzheimer's disease. Exelon is approved by FDA to moderate dementia.
Generic Exelon may be sold as Rivastigmine transdermal.
*Exelon® is a brand product of Novartis Pharmaceuticals.